Kronos Bio, Inc.
KRON
$0.88
$0.01291.49%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 72.08% | -1.95% | 55.03% | 45.53% | -14.18% |
| Total Depreciation and Amortization | -53.68% | -14.44% | -19.22% | -27.46% | -16.52% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -77.37% | 248.88% | -63.63% | -69.98% | 130.48% |
| Change in Net Operating Assets | 7.99% | 0.53% | -128.48% | 34.11% | -163.32% |
| Cash from Operations | 46.27% | 48.71% | 45.23% | 34.75% | -301.87% |
| Capital Expenditure | -- | 87.10% | 103.27% | 100.00% | 94.44% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 243.57% | -29.21% | -52.44% | 607.07% | 192.74% |
| Cash from Investing | 243.99% | -29.15% | -52.14% | 647.60% | 190.79% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -57.07% | -- | -56.38% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -57.07% | -- | -56.38% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 138.65% | 42.81% | -63.97% | 224.57% | -47.37% |